0001181431-14-034087.txt : 20141008 0001181431-14-034087.hdr.sgml : 20141008 20141008201401 ACCESSION NUMBER: 0001181431-14-034087 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141006 FILED AS OF DATE: 20141008 DATE AS OF CHANGE: 20141008 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ORGANOVO HOLDINGS, INC. CENTRAL INDEX KEY: 0001497253 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 271488943 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 6275 NANCY RIDGE DRIVE STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-550-9994 MAIL ADDRESS: STREET 1: 6275 NANCY RIDGE DRIVE STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: REAL ESTATE RESTORATION & RENTAL, INC. DATE OF NAME CHANGE: 20100722 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Presnell Sharon Collins CENTRAL INDEX KEY: 0001536585 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35996 FILM NUMBER: 141149073 MAIL ADDRESS: STREET 1: 6275 NANCY RIDGE DRIVE, SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 rrd417337.xml X0306 4 2014-10-06 0 0001497253 ORGANOVO HOLDINGS, INC. ONVO 0001536585 Presnell Sharon Collins 6275 NANCY RIDGE DRIVE, SUITE 110 SAN DIEGO CA 92121 0 1 0 0 EVP, Research & Dev & CTO Common Stock 2014-10-06 4 S 0 50000 6.1095 D 24064 D The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $6.025 to $6.35 The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. This number does not include 1,021,192 shares of common stock underlying outstanding options held by Dr. Presnell; post-transaction Dr. Presnell continues to beneficially own or have a right to acquire 1,045,256 shares of common stock. /s/ Sharon Collins Presnell 2014-10-08